Ionis wins first-ever FDA approval for Alexander disease therapy on September 04, 2026 Alexander Disease Approved Glial Fibrillary Acidic Protein Ionis Pharmaceuticals neurology pipeline Rare Diseases Recordati RNA-targeted therapy United States Food and Drug Administration Zanvastro Zilganersen +
Recordati licenses Ionis drug on June 26, 2026 Alexander Disease BARDA funding cut Ionis Norovirus Recordati Vaccines Vaxart Zilganersen +
Recordati hit with €10.7B tender offer on May 22, 2026 Arthrosi central venous catheter (CVC) sets delist Gout Suppressants Groupe Bruxelles Lambert Phase 3 Recordati Sobi Tender +
Recordati Confirms Non-Binding €10.9 Billion Full Takeover Offer from CVC Capital Partners on March 27, 2026 Capital central venous catheter (CVC) sets Dosage Forms Recordati takeover +